Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 54.70
-0.30 (-0.55%)
Jul 10, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 678.05 million as of July 10, 2026. Its market cap has increased by 13.72% in one year.
Market Cap
678.05M
Enterprise Value
607.47M
Revenue
232.38M
Ranking
n/a
PE Ratio
17.41
Stock Price
54.70
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 678.05M, an increase of 27.14%. That is a compound annual growth rate of 1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 678.05M | 0.88% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.61B |
| Idorsia | 1.58B |
| Newron Pharmaceuticals | 245.51M |
| Santhera Pharmaceuticals Holding AG | 227.94M |
| BioVersys AG | 161.00M |
| Molecular Partners AG | 121.16M |
| Xlife Sciences AG | 103.50M |
| MindMaze Therapeutics Holding | 26.52M |